Europe — EMA
Paclitaxel Fresenius Kabi
Paclitaxel, the active ingredient in Paclitaxel Fresenius Kabi, is a taxane presented as a sterile injectable solution for intravenous use.
Request sourcing
What is Paclitaxel?
Paclitaxel, the active ingredient in Paclitaxel Fresenius Kabi, is a taxane presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various solid tumours and is administered under the supervision of oncology specialists.
GNH USA supplies Paclitaxel Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.
What is Paclitaxel used for?
Paclitaxel is a chemotherapeutic agent that interferes with cell division across a range of solid tumours. - Breast cancer: Improves the overall response rate when combined with anthracycline‑based regimens. - Non‑small cell lung cancer: Enhances the progression‑free survival as part of first‑line therapy. - Ovarian cancer: Contributes to tumour reduction and maintenance of the remission status by adding the ‑
What are the side effects of Paclitaxel?
The
Product details
Related products
Paclitaxel 100 mg/20mL
Paclitaxel · 100 mg/20 mL
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND 100 mg/20mL
Paclitaxel · 100 mg/20 mL
Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL
Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL